GS-5806 Inhibits a Broad Range of Respiratory Syncytial Virus Clinical Isolates by Blocking the Virus-Cell Fusion Process

Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in infants and young children. In addition, RSV causes significant morbidity and mortality in hospitalized elderly and immunocompromised patients. Currently, only palivizumab, a monoclonal antibody against the...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Antimicrob Agents Chemother
Glavni autori: Perron, Michel, Stray, Kirsten, Kinkade, April, Theodore, Dorothy, Lee, Gary, Eisenberg, Eugene, Sangi, Michael, Gilbert, Brian E., Jordan, Robert, Piedra, Pedro A., Toms, Geoffery L., Mackman, Richard, Cihlar, Tomas
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2016
Teme:
Antiviral Agents
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4776015/
https://ncbi.nlm.nih.gov/pubmed/26666922
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01497-15
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items